Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT04879121 · RECRUITING

Trial details

NCT number: NCT04879121
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Malignant Solid Neoplasm Metastatic Malignant Solid Neoplasm

Start date: 2021-04-30
Primary completion: 2027-11-11
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.